Total assets contracted 82% to $45.8B, debt-to-equity spiked to 2.70, and retained earnings fell 99% to $118.5M, indicating severe deleveraging and potential impairment risk.
Jbs N.V. (JBS) balance sheet — 12-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 |
|---|
| Total Current Assets | 17.76B | 101.4B | 655.62B | 386.36B | 79.39B | 83.91B | 60.54B | 41.92B | 36.9B | 36.11B | 33.92B | 49.81B | 37.54B |
| Cash & Short-Term Investments | 3.47B | 25.98B | 214.97B | 108.74B | 13.18B | 23.24B | 19.68B | 10.03B | 8.94B | 11.74B | 9.36B | 18.84B | 14.91B |
| Cash Only | 3.47B | 25.11B | 214.97B | 108.74B | 13.18B | 23.24B | 19.68B | 10.03B | 8.94B | 11.74B | 9.36B | 18.84B | 8.37B |
| Short-Term Investments | 0 | 877.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.54B |
| Accounts Receivable | 3.56B | 29.4B | 143.05B | 80.69B | 20.23B | 19.88B | 14B | 11.14B | 9.66B | 9.33B | 9.59B | 12.12B | 9.58B |
| Days Sales Outstanding | 19.8 | 22.78 | 125.22 | 80.95 | 19.24 | 20.01 | 18.91 | 19.87 | 19.4 | 20.88 | 20.54 | 27.15 | 29.02 |
| Inventory | 7B | 43.63B | 253.66B | 162.13B | 37.85B | 33.95B | 22.7B | 17.35B | 14.5B | 12.45B | 12.28B | 13.98B | 9.84B |
| Days Inventory Outstanding | 37.9 | 38.77 | 261.41 | 182.55 | 42.78 | 42.15 | 36.83 | 36.69 | 34.08 | 32.6 | 30.07 | 36.37 | 35.29 |
| Other Current Assets | 3.74B | 2.38B | 43.94B | 34.8B | 8.12B | 6.85B | 4.15B | 3.41B | 3.8B | 2.58B | 2.69B | 4.86B | 3.03B |
| Total Non-Current Assets | 28.08B | 146.94B | 902.35B | 626.82B | 128.72B | 123.34B | 103.26B | 84.42B | 77.25B | 72.59B | 68.9B | 72.69B | 44.5B |
| Property, Plant & Equipment | 16.04B | 62.58B | 532.12B | 360.63B | 73.16B | 67.05B | 54.74B | 44.06B | 36.28B | 34.53B | 34.09B | 36.48B | 24.73B |
| Fixed Asset Turnover | 7.00x | 7.53x | 0.78x | 1.01x | 5.25x | 5.41x | 4.94x | 4.64x | 5.01x | 4.73x | 5.00x | 4.47x | 4.87x |
| Goodwill | 5.98B | 32.19B | 207.44B | 145.27B | 30.41B | 32.56B | 28.89B | 24.5B | 23.78B | 22.49B | 21.92B | 24.41B | 12.99B |
| Intangible Assets | 1.78B | 10.04B | 69.05B | 47.25B | 10.33B | 12B | 7.82B | 6.05B | 5.82B | 5.51B | 5.01B | 6.89B | 2.45B |
| Long-Term Investments | 53.77B | 26.13B | 1.47B | 1.35B | 294.84M | 243.19M | 171.1M | 93.63M | 84.97M | 64.01M | 362.63M | 354.13M | 295.35M |
| Other Non-Current Assets | 3.34B | 13B | 92.28B | 72.31B | 14.52B | 11.48B | 11.65B | 9.71B | 11.29B | 10B | 7.52B | 4.55B | 4.04B |
| Total Assets | 45.84B | 248.34B | 1.56T | 1.01T | 208.11B | 207.25B | 163.8B | 126.34B | 114.15B | 108.7B | 102.82B | 122.5B | 82.04B |
| Asset Turnover | 2.00x | 1.90x | 0.27x | 0.36x | 1.85x | 1.75x | 1.65x | 1.62x | 1.59x | 1.50x | 1.66x | 1.33x | 1.47x |
| Asset Growth % | -80.03% | -84.06% | 53.77% | 386.84% | 0.41% | 26.53% | 29.65% | 10.68% | 5.01% | 5.72% | -16.07% | 49.31% | - |
| Total Current Liabilities | 11.58B | 63.48B | 446.39B | 235.51B | 55.16B | 59.81B | 40.84B | 28.46B | 21.6B | 29.18B | 33.35B | 40.14B | 24.87B |
| Accounts Payable | 5.85B | 40.33B | 209.29B | 125.1B | 31.01B | 30.22B | 22.2B | 15.44B | 12.17B | 9.99B | 10.72B | 12.42B | 6.94B |
| Days Payables Outstanding | 31.26 | 35.83 | 215.69 | 140.85 | 35.05 | 37.51 | 36.01 | 32.65 | 28.58 | 26.17 | 26.24 | 32.31 | 24.89 |
| Short-Term Debt | 1.33B | 6.53B | 107.72B | 43.78B | 11.3B | 14.6B | 6.66B | 4.09B | 3.83B | 13.53B | 18.15B | 20.91B | 13.69B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 922.39M | 6.45B | 57.19B | 23.95B | 4.09B | 5.66B | 4.33B | 3.37B | 1.57B | 2.17B | 1.46B | 3.55B | 2.13B |
| Current Ratio | 1.53x | 1.60x | 1.47x | 1.64x | 1.44x | 1.40x | 1.48x | 1.47x | 1.71x | 1.24x | 1.02x | 1.24x | 1.51x |
| Quick Ratio | 0.93x | 0.91x | 0.90x | 0.95x | 0.75x | 0.84x | 0.93x | 0.86x | 1.04x | 0.81x | 0.65x | 0.89x | 1.11x |
| Cash Conversion Cycle | 26.44 | 25.72 | 170.95 | 122.65 | 26.97 | 24.65 | 19.73 | 23.91 | 24.89 | 27.32 | 24.37 | 31.22 | 39.41 |
| Total Non-Current Liabilities | 25.2B | 132.5B | 800.1B | 546.66B | 103.14B | 99.65B | 79.42B | 65.4B | 64.6B | 53.38B | 45.95B | 52.74B | 31.53B |
| Long-Term Debt | 21.32B | 111.41B | 660.27B | 454.68B | 84.13B | 80.6B | 61.34B | 50.95B | 53.23B | 43.5B | 38.11B | 44.98B | 26.39B |
| Capital Lease Obligations | 24.19B | 7.77B | 53.55B | 35.42B | 7.2B | 6.78B | 4.81B | 3.77B | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 19.51B | 6.43B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.28B | 6.89B | 86.28B | 56.56B | 11.82B | 12.26B | 13.27B | 10.68B | 11.37B | 9.88B | 7.84B | 7.77B | 5.14B |
| Total Liabilities | 36.78B | 195.97B | 1.25T | 782.17B | 158.3B | 159.45B | 120.26B | 93.86B | 86.2B | 82.56B | 79.3B | 92.88B | 56.4B |
| Total Debt | 24.44B | 125.71B | 834.39B | 542.27B | 104.41B | 103.61B | 74.11B | 59.75B | 57.06B | 57.02B | 56.26B | 65.88B | 40.08B |
| Net Debt | 20.98B | 100.6B | 619.43B | 433.53B | 91.23B | 80.37B | 54.43B | 49.72B | 48.13B | 45.28B | 46.9B | 47.04B | 31.71B |
| Debt / Equity | 2.70x | 2.40x | 2.68x | 2.35x | 2.10x | 2.17x | 1.70x | 1.84x | 2.04x | 2.18x | 2.39x | 2.22x | 1.56x |
| Debt / EBITDA | 0.95x | 3.57x | 24.94x | 38.57x | 2.95x | 2.43x | 2.76x | 3.22x | 4.78x | 5.10x | 5.09x | 5.15x | 3.73x |
| Net Debt / EBITDA | 0.81x | 2.85x | 18.51x | 30.83x | 2.58x | 1.88x | 2.03x | 2.68x | 4.03x | 4.05x | 4.24x | 3.68x | 2.95x |
| Interest Coverage | 2.66x | 2.57x | 15.60x | 3.44x | 19.28x | 34.51x | 5.65x | 3.24x | 2.01x | 1.49x | 2.12x | 3.71x | 2.99x |
| Total Equity | 9.06B | 52.37B | 311.49B | 231B | 49.81B | 47.8B | 43.54B | 32.48B | 27.95B | 26.14B | 23.52B | 29.62B | 25.64B |
| Equity Growth % | -81.3% | -83.19% | 34.84% | 363.78% | 4.21% | 9.77% | 34.06% | 16.23% | 6.91% | 11.16% | -20.61% | 15.52% | - |
| Book Value per Share | 8.87 | 49.01 | 140.43 | 104.14 | 22.09 | 19.28 | 16.40 | 12.18 | 10.48 | 9.19 | 8.60 | 10.22 | 8.90 |
| Total Shareholders' Equity | 8.22B | 47.87B | 276.92B | 213.08B | 46.34B | 44.12B | 40.12B | 29.64B | 25.65B | 24.29B | 22.37B | 28.03B | 23.87B |
| Common Stock | 41.56M | 171.18M | 145.8B | 115.88B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 23.58B | 21.51B |
| Retained Earnings | 118.48M | 11.5B | 113.46B | 75.59B | 18.65B | 13.49B | 7.17B | 5.22B | 2.49B | 2.28B | 3.65B | 4.76B | 4.26B |
| Treasury Stock | 0 | -3.25B | 0 | 0 | 0 | -3.04B | -303.56M | -605.72M | -624.14M | 0 | -1.63B | -903.57M | -451.7M |
| Accumulated OCI | 0 | 39.44B | 16.36B | 20.56B | 3.9B | 9.88B | 9.47B | 1.23B | -10.39M | -1.78B | -3.44B | 387.79M | -1.66B |
| Minority Interest | 834.76M | 4.51B | 34.57B | 17.93B | 3.46B | 3.68B | 3.42B | 2.85B | 2.3B | 1.85B | 1.14B | 1.59B | 1.77B |
Quick answers to the most common questions about buying JBS stock.
As of 2025, Jbs N.V. (JBS) had total assets of $248.34B including $101.40B in current assets.
Jbs N.V. (JBS) carries total debt of $125.71B, offset by $25.98B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Jbs N.V. (JBS) has total shareholders' equity (book value) of $47.87B ($49.01 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Jbs N.V. (JBS) reported a current ratio of 1.60x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
High leverage and margin compression
Metrics are mathematically derived from official filings.
Balance Sheet Shrinks Sharply
Total assets contracted from $251.9B in 2024Q4 to $45.8B in 2026Q2, a 82% decline, while equity fell from $44.8B to $8.2B, indicating a severe deleveraging or restructuring, per reported figures.
The dramatic reduction in total assets and equity over the last two quarters suggests a major corporate event, possibly a spin-off or asset sale, rather than organic contraction. This shift may indicate a strategic refocusing, but it also raises questions about the quality and composition of the remaining asset base. Investors should monitor whether this downsizing improves operational efficiency or simply reflects distress.
Leverage Spikes to Critical Levels
Debt-to-equity ratio surged to 2.70 in 2026Q2 from 2.30 a year earlier, while total debt of $24.4B now exceeds equity by 3x, based on the latest balance sheet data, signaling heightened financial risk.
The increase in leverage, despite a reduction in absolute debt, is driven by the collapse in equity, which fell from $45.9B to $8.2B. This suggests that the company's net worth has been eroded, possibly due to impairments or losses, making the debt burden relatively heavier. The high D/E ratio, combined with thin operating margins, implies limited cushion for further earnings shocks and may constrain future borrowing capacity.
Asset Base Shifts Toward Tangibles
PP&E net of $16.0B now represents 35% of total assets in 2026Q2, up from 34% in 2024Q4, while goodwill fell from $33.5B to $6.0B, indicating a potential impairment or divestiture, as per the balance sheet.
The significant reduction in goodwill and intangibles suggests that the company may have written down or sold previously acquired businesses, which could indicate a strategic pivot away from M&A-driven growth. The relative increase in tangible assets like PP&E implies a more asset-heavy model, which may require sustained capital expenditure to maintain. This shift could improve asset quality but also increases fixed costs and depreciation burden.
Equity Base Eroded by Losses
Retained earnings plummeted from $18.3B in 2024Q4 to $118.5M in 2026Q2, a 99% decline, while total equity fell to $8.2B, according to the latest balance sheet, reflecting severe earnings deterioration.
The collapse in retained earnings is consistent with the reported net loss in 2026Q2 and the prior quarters' margin compression. This erosion of equity reduces the company's ability to absorb future shocks and may limit its capacity to pay dividends or invest in growth. The negative EPS and thin operating margins suggest that the equity base could be further impaired if profitability does not recover.
Liquidity Buffer Thins Rapidly
Cash and equivalents fell from $34.8B in 2024Q4 to $3.5B in 2026Q2, a 90% drop, while the current ratio improved slightly to 1.53, based on reported figures, indicating a shrinking liquidity cushion.
The dramatic reduction in cash reserves, despite a stable current ratio, suggests that the company has used its cash to pay down debt or fund operations during a period of negative free cash flow. The current ratio of 1.53 provides some short-term comfort, but the absolute cash level is now low relative to the company's scale, potentially limiting its ability to weather further operational disruptions or invest in working capital.
Goodwill Impairment Risk Looms
Goodwill of $6.0B remains on the balance sheet in 2026Q2, but given the sharp revenue decline and negative earnings, further impairments may be likely, as per the latest data, which could erode equity further.
The substantial reduction in goodwill from $33.5B to $6.0B suggests that the company has already taken significant impairment charges, possibly related to its US beef or other segments. However, the remaining goodwill is still material relative to equity, and if the business continues to underperform, additional write-downs could further reduce book value. This risk is heightened by the recent EPS miss and margin compression, which may indicate that the acquired businesses are not generating expected returns.